T3	Effect 81 96	frequent shocks
T4	Treatment 97 129	during oral procainamide therapy
T5	Subject 0 70	A 78-year-old man with a transvenous cardioverter defibrillator system
T7	Age 2 13	78-year-old
T8	Gender 14 17	man
T9	Treat-Disorder 23 70	a transvenous cardioverter defibrillator system
T10	Route 104 108	oral
T11	Drug 109 121	procainamide
T6	Adverse_event 71 80	developed
E1	Adverse_event:T6 
